Extracellular Synthesis of Bioactive Silver Nanoparticles Using Brevibacillus sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens Listeria monocytogenes and Yersinia enterocolitica

The purpose of current study was the green synthesis of bioactive silver nanoparticles (AgNPs) using <i>Brevibacillus</i> sp. MAHUQ-41 and the exploration of their role in controlling drug-resistant bacterial pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>. The culture supernatant of strain MAHUQ-41 was employed for a simple and eco-friendly synthesis of biofunctional silver nanoparticles (AgNPs). The resulting nanoparticles were analyzed using several techniques, including UV-Visible spectroscopy, XRD, FE-TEM, FTIR, and DLS. The UV-Vis spectral analysis of the AgNPs synthesized via <i>Brevibacillus</i> sp. MAHUQ-41 revealed a prominent absorption peak at 400 nm. FE-TEM results confirmed spherical-shaped 15-60 nm sized nanoparticles. XRD results indicated that the synthesized AgNPs were crystalline in nature. The FTIR spectrum determined various functional groups on the surface of synthesized nanoparticles. Potent antibacterial properties were observed in green-synthesized AgNPs against tested pathogens. The MIC value of extracellular synthesized AgNPs for both pathogenic bacteria was 6.2 µg/mL, and the MBCs were 25.0 µg/mL and 12.5 µg/mL for <i>L. monocytogenes</i> and <i>Y. enterocolitica,</i> respectively. Treatment by synthesized AgNPs resulted in morphological alterations and structural damages in both <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>. These alterations can interfere with regular cellular activities, potentially resulting in cell death. This study is the first to report the antimicrobial properties of silver nanoparticles synthesized using <i>Brevibacillus</i> sp. MAHUQ-41. The findings obtained in the present study supported the role of <i>Brevibacillus</i> sp. MAHUQ-41-mediated synthesized AgNPs in controlling drug-resistant bacterial pathogens <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>.

Authors

Institutions

Publication Details

Journal
Journal of Functional Biomaterials
Published
2025-06-30
DOI
https://doi.org/10.3390/jfb16070241
Citations
3
Primary Topic
Nanoparticles: synthesis and applications
Type
article
Field-Weighted Citation Impact
1.55
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Extracellular Synthesis of Bioactive Silver Nanoparticles Using Brevibacillus sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens Listeria monocytogenes and Yersinia enterocolitica

Md. Amdadul Huq
3 citations
Journal of Functional Biomaterials
Nanoparticles: synthesis and applications
1.55
article

Extracellular Synthesis of Bioactive Silver Nanoparticles Using Brevibacillus sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens Listeria monocytogenes and Yersinia enterocolitica

Md. Amdadul Huq
article en
3 citations

Abstract

The purpose of current study was the green synthesis of bioactive silver nanoparticles (AgNPs) using <i>Brevibacillus</i> sp. MAHUQ-41 and the exploration of their role in controlling drug-resistant bacterial pathogens <i>Listeria monocytogenes</i> and <i>Yersinia enterocolitica</i>. The culture supernatant of strain MAHUQ-41 was employed for a simple and eco-friendly synthesis of biofunctional silver nanoparticles (AgNPs). The resulting nanoparticles were analyzed using several techniques, including UV-Visible spectroscopy, XRD, FE-TEM, FTIR, and DLS. The UV-Vis spectral analysis of the AgNPs synthesized via <i>Brevibacillus</i> sp. MAHUQ-41 revealed a prominent absorption peak at 400 nm. FE-TEM results confirmed spherical-shaped 15-60 nm sized nanoparticles. XRD results indicated that the synthesized AgNPs were crystalline in nature. The FTIR spectrum determined various functional groups on the surface of synthesized nanoparticles. Potent antibacterial properties were observed in green-synthesized AgNPs against tested pathogens. The MIC value of extracellular synthesized AgNPs for both pathogenic bacteria was 6.2 µg/mL, and the MBCs were 25.0 µg/mL and 12.5 µg/mL for <i>L. monocytogenes</i> and <i>Y. enterocolitica,</i> respectively. Treatment by synthesized AgNPs resulted in morphological alterations and structural damages in both <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>. These alterations can interfere with regular cellular activities, potentially resulting in cell death. This study is the first to report the antimicrobial properties of silver nanoparticles synthesized using <i>Brevibacillus</i> sp. MAHUQ-41. The findings obtained in the present study supported the role of <i>Brevibacillus</i> sp. MAHUQ-41-mediated synthesized AgNPs in controlling drug-resistant bacterial pathogens <i>L. monocytogenes</i> and <i>Y. enterocolitica</i>.

Journal of Functional BiomaterialsVol. 16(7)
Gachon University (KR)
Openalex Percentile: Top 17%
Nanoparticles: synthesis and applications
1.55
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Extracellular Synthesis of Bioactive Silver Nanoparticles Using Brevibacillus sp. MAHUQ-41 and Their Potential Application Against Drug-Resistant Bacterial Pathogens Listeria monocytogenes and Yersinia enterocolitica — Md. Amdadul Huq · Journal of Functional Biomaterials (2025) | TGRS Research Map | TGRS